Matches in SemOpenAlex for { <https://semopenalex.org/work/W1971493890> ?p ?o ?g. }
- W1971493890 endingPage "108" @default.
- W1971493890 startingPage "87" @default.
- W1971493890 abstract "Based on the experience to date with IPMNs, the approach to patients remains relatively complex. A meticulous and careful approach to diagnosis, oncologic risk assessment, operative planning, and surveillance is needed to adequately address these lesions. Indications for resection in patients with IPMN are (1) cancer, (2) cancer prevention in patients at high risk for malignant transformation, and (3) management of symptoms. Differentiating patients who have IPMNs by type is an important initial step in providing optimal care (Fig. 6). In patients with MPD involvement (main- and mixed-type IPMN), the risk of malignancy at resection is too high to justify nonoperative management unless comorbidity or patient preference precludes operation. Until better preoperative biomarkers of malignancy in main duct-involved IPMNs are available, it is our recommendation that all patients who are fit should undergo resection of the entire involved segment with appropriate adjustment and extension based on intraoperative pathology. Total pancreatectomy may be indicated for diffuse main duct involvement. In the more difficult and debated cohort (i.e., patients with side branch disease only), a more strategic approach to whether to resect is appropriate. Patients with malignant cytopathology, concerning radiologic features (i.e., mural nodules, associated mass), or symptoms attributable to IPMNs should be offered resection. Importantly, specific symptoms have variable importance in terms of oncologic risk and are worth characterizing in individual patients. Size alone should not be the determining oncologic factor for resection, although we acknowledge that the literature is unclear in this regard. Size of IPMNs (or any other cystic lesion) may be a nononcologic indication to resect for symptom control and when size or anticipated growth may complicate the ability to safely extirpate the lesion. Other factors that should be considered in determining whether to resect are number of lesions, need for prolonged surveillance, inability to adequately perform noninvasive surveillance (e.g., contraindication to MRI), difficulty in surveillance (extensive/diffuse multifocal disease), and patient tolerance of risk. The decision to resect in patients undergoing primary surveillance or secondary surveillance for IPMN should be similar to the indications for primary resection noted previously. The optimal surveillance regimen, however, is unknown. The optimal surveillance regimen depends on the timing and incidence of recurrence and new metachronous IPMIN development, which are not fully understood, partly because of suboptimal preoperative imaging in patients with IPMNs. To solve this mystery, surgeons and pancreatologists should be encouraged to obtain optimal and timely imaging studies before taking patients to the operating room. Patients should be followed at least annually with history and physical and optimal cross-sectional imaging. Endoscopy and cytopathologic assessment should be considered at least biannually and more often when indicated by patient symptoms or concerning radiographic features. The surveillance interval should be decreased and extent of testing increased based on patients with higher oncologic risk stratification. Although resection in patients undergoing surveillance currently follows the same algorithm as patients undergoing primary resection, assessment of the main pancreatic duct in patients undergoing secondary surveillance after segmental pancreatectomy (particularly pancreaticoduodenectomy) is complicated. Although new data continue to clarify how and when to approach IPMNs with segmental or total pancreatic resection, many questions remain unanswered. Continued efforts to uncover a more accurate natural history and behavior for IPMN continue to fill the gaps in our current understanding and practice. In the meantime, it is critical to educate and frequently restratify oncologic risk in patients based on optimal and timely data (history and physical and radiographic, endoscopic, and cytopathologic results) and rigorous follow-up to guide patients in reaching a decision of whether and when to undergo IPMN resection." @default.
- W1971493890 created "2016-06-24" @default.
- W1971493890 creator A5015843387 @default.
- W1971493890 creator A5034960927 @default.
- W1971493890 date "2008-09-01" @default.
- W1971493890 modified "2023-10-16" @default.
- W1971493890 title "Intraductal Papillary Mucinous Neoplasm—When to Resect?" @default.
- W1971493890 cites W1963617191 @default.
- W1971493890 cites W1964343772 @default.
- W1971493890 cites W1966414268 @default.
- W1971493890 cites W1968719959 @default.
- W1971493890 cites W1973453594 @default.
- W1971493890 cites W1973739299 @default.
- W1971493890 cites W1974615817 @default.
- W1971493890 cites W1982065575 @default.
- W1971493890 cites W1991692850 @default.
- W1971493890 cites W1998154281 @default.
- W1971493890 cites W2003919433 @default.
- W1971493890 cites W2006534562 @default.
- W1971493890 cites W2012794165 @default.
- W1971493890 cites W2019672511 @default.
- W1971493890 cites W2022831693 @default.
- W1971493890 cites W2024476159 @default.
- W1971493890 cites W2027546717 @default.
- W1971493890 cites W2042570525 @default.
- W1971493890 cites W2045117654 @default.
- W1971493890 cites W2051953780 @default.
- W1971493890 cites W2052402740 @default.
- W1971493890 cites W2054465459 @default.
- W1971493890 cites W2060110869 @default.
- W1971493890 cites W2066326010 @default.
- W1971493890 cites W2067877744 @default.
- W1971493890 cites W2068516781 @default.
- W1971493890 cites W2073400663 @default.
- W1971493890 cites W2083400359 @default.
- W1971493890 cites W2085014500 @default.
- W1971493890 cites W2087048205 @default.
- W1971493890 cites W2088026097 @default.
- W1971493890 cites W2090986863 @default.
- W1971493890 cites W2100014692 @default.
- W1971493890 cites W2101597736 @default.
- W1971493890 cites W2103803226 @default.
- W1971493890 cites W2119816538 @default.
- W1971493890 cites W2123875049 @default.
- W1971493890 cites W2132097957 @default.
- W1971493890 cites W2135621010 @default.
- W1971493890 cites W2155814955 @default.
- W1971493890 cites W2527666644 @default.
- W1971493890 cites W582188491 @default.
- W1971493890 doi "https://doi.org/10.1016/j.yasu.2008.03.011" @default.
- W1971493890 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18953811" @default.
- W1971493890 hasPublicationYear "2008" @default.
- W1971493890 type Work @default.
- W1971493890 sameAs 1971493890 @default.
- W1971493890 citedByCount "41" @default.
- W1971493890 countsByYear W19714938902012 @default.
- W1971493890 countsByYear W19714938902013 @default.
- W1971493890 countsByYear W19714938902014 @default.
- W1971493890 countsByYear W19714938902015 @default.
- W1971493890 countsByYear W19714938902016 @default.
- W1971493890 countsByYear W19714938902019 @default.
- W1971493890 countsByYear W19714938902021 @default.
- W1971493890 crossrefType "journal-article" @default.
- W1971493890 hasAuthorship W1971493890A5015843387 @default.
- W1971493890 hasAuthorship W1971493890A5034960927 @default.
- W1971493890 hasConcept C121608353 @default.
- W1971493890 hasConcept C126322002 @default.
- W1971493890 hasConcept C126838900 @default.
- W1971493890 hasConcept C141071460 @default.
- W1971493890 hasConcept C159110652 @default.
- W1971493890 hasConcept C2776469228 @default.
- W1971493890 hasConcept C2778494859 @default.
- W1971493890 hasConcept C2778764654 @default.
- W1971493890 hasConcept C2779399171 @default.
- W1971493890 hasConcept C61434518 @default.
- W1971493890 hasConcept C71924100 @default.
- W1971493890 hasConcept C72563966 @default.
- W1971493890 hasConceptScore W1971493890C121608353 @default.
- W1971493890 hasConceptScore W1971493890C126322002 @default.
- W1971493890 hasConceptScore W1971493890C126838900 @default.
- W1971493890 hasConceptScore W1971493890C141071460 @default.
- W1971493890 hasConceptScore W1971493890C159110652 @default.
- W1971493890 hasConceptScore W1971493890C2776469228 @default.
- W1971493890 hasConceptScore W1971493890C2778494859 @default.
- W1971493890 hasConceptScore W1971493890C2778764654 @default.
- W1971493890 hasConceptScore W1971493890C2779399171 @default.
- W1971493890 hasConceptScore W1971493890C61434518 @default.
- W1971493890 hasConceptScore W1971493890C71924100 @default.
- W1971493890 hasConceptScore W1971493890C72563966 @default.
- W1971493890 hasLocation W19714938901 @default.
- W1971493890 hasLocation W19714938902 @default.
- W1971493890 hasOpenAccess W1971493890 @default.
- W1971493890 hasPrimaryLocation W19714938901 @default.
- W1971493890 hasRelatedWork W1602205444 @default.
- W1971493890 hasRelatedWork W2079527521 @default.
- W1971493890 hasRelatedWork W2106656639 @default.
- W1971493890 hasRelatedWork W2280664730 @default.
- W1971493890 hasRelatedWork W2430440503 @default.